Chronic myeloid leukemia (CML) is a type of blood cancer that arises due to a genetic translocation between chromosomes 9 and 22, leading to the expression of a constitutively active tyrosine kinase oncogene called BCR::ABL1 [1]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.